How should an acute inferior‑wall myocardial infarction be treated acutely, including antiplatelet therapy, anticoagulation, reperfusion strategy, nitrates, β‑blockers, oxygen use, and management of potential bradyarrhythmias?

Acute Management of Inferior Wall Myocardial Infarction

Immediate primary percutaneous coronary intervention (PCI) within 90 minutes is the definitive treatment for acute inferior wall MI, combined with dual antiplatelet therapy (aspirin plus ticagrelor), unfractionated heparin, and careful avoidance of nitrates until right ventricular involvement is excluded. 1

Immediate Antiplatelet and Anticoagulation Therapy

At first medical contact, administer aspirin 162–325 mg (chewed for rapid absorption) and ticagrelor 180 mg loading dose. 2 These should be given immediately, ideally in the ambulance or emergency department before catheterization. 2

• Unfractionated heparin (UFH) is the preferred anticoagulant, given as a weight-adjusted bolus of approximately 70 U/kg followed by continuous infusion. 2 Start this immediately while arranging catheterization. 2
• Do not use clopidogrel as first-line therapy—it is reserved only for patients receiving fibrinolysis or when ticagrelor/prasugrel are contraindicated. 2
• Continue aspirin 75–100 mg daily indefinitely and ticagrelor 90 mg twice daily for 12 months post-PCI. 1, 2

Reperfusion Strategy

Primary PCI is the preferred reperfusion method and must be performed within 90 minutes of first medical contact at a PCI-capable facility, or within 120 minutes if transfer is required. 1, 2

• If these time windows cannot be met, administer fibrinolytic therapy within 30 minutes of diagnosis using fibrin-specific agents (tenecteplase, alteplase, or reteplase). 2
• After successful fibrinolysis, perform angiography and PCI of the infarct-related artery between 2–24 hours. 1
• Rescue PCI is indicated immediately if fibrinolysis fails (defined as <50% ST-segment resolution at 60–90 minutes) or if hemodynamic/electrical instability develops. 1

Critical Assessment for Right Ventricular Infarction

Before administering any nitrates, obtain a right-sided ECG (lead V4R) to exclude right ventricular (RV) infarction, which occurs in up to 50% of inferior MIs and dramatically alters management. 3, 4

• ST-segment elevation ≥1 mm in lead V4R has 88% sensitivity and 78% specificity for RV infarction. 3 Record this early, as ST elevation can resolve within 10 hours. 3, 4
• Look for the clinical triad: hypotension, clear lung fields, and elevated jugular venous pressure (though this is only 25% sensitive). 3, 4

Management of RV Infarction

If RV infarction is present, aggressive IV normal saline volume loading is first-line therapy to maintain RV preload. 3, 4 The ischemic right ventricle is preload-dependent. 3

• Absolutely avoid nitrates and diuretics—they can cause profound hypotension by reducing preload. 3, 4
• If cardiac output remains low after adequate volume loading, add dobutamine starting at 2.5 μg/kg/min (not dopamine). 3
• For persistent shock despite volume and inotropes, consider intra-aortic balloon pump. 3, 4
• Maintain AV synchrony through AV sequential pacing if symptomatic high-degree heart block develops and is unresponsive to atropine. 3, 4

Nitrate Use (Only if RV Infarction Excluded)

In hemodynamically stable patients without RV involvement, IV nitroglycerin may be used for persistent chest pain, hypertension, or pulmonary edema. 4

• Start at 5 μg/min and titrate by 5–10 μg/min every 3–5 minutes, targeting a 10–20% reduction in mean arterial pressure. 4
• Absolute contraindications: systolic BP <90 mmHg, confirmed/suspected RV infarction, severe bradycardia (<50 bpm), or use of phosphodiesterase-5 inhibitors within 24–48 hours. 4
• Continue for 24–48 hours if ischemia persists; routine long-term use is not supported. 1, 4

Beta-Blocker Therapy

Do not give IV beta-blockers acutely in inferior MI—they are contraindicated in hypotension, acute heart failure, high-grade AV block, severe bradycardia, or cardiogenic shock. 1, 2

• Start oral beta-blockers within 24 hours only in hemodynamically stable patients, then continue long-term in those with heart failure or LVEF <40%. 1

Oxygen Therapy

Supplemental oxygen is not recommended unless peripheral oxygen saturation is <90%. 2 Routine oxygen in non-hypoxemic patients provides no benefit and may be harmful. 2

Management of Bradyarrhythmias

Sinus bradycardia is common in the first hour of inferior MI and often requires no treatment unless accompanied by hypotension. 1, 4

• For symptomatic bradycardia with hypotension, give IV atropine 0.3–0.5 mg, repeated up to a total of 1.5–2.0 mg. 1, 4
• First-degree AV block requires no treatment. 1
• Type I second-degree (Mobitz I/Wenckebach) AV block is usually benign and associated with inferior MI; treat only if hemodynamically significant, first with atropine, then pacing if needed. 1
• Type II second-degree (Mobitz II) and complete AV block are indications for temporary pacing, especially if causing hypotension or heart failure. 1, 4 However, recent evidence suggests primary PCI without temporary pacing is acceptable in complete AVB-complicated inferior STEMI to avoid delay in reperfusion. 5, 6

Additional Mandatory Therapies

Start high-intensity statin therapy immediately with a target LDL-C <1.8 mmol/L (70 mg/dL). 1, 2

ACE inhibitors should be started within the first 24 hours in patients with heart failure, LVEF <40%, diabetes, or anterior infarct (though inferior MI with these features also benefits). 1, 2

• Use an ARB (preferably valsartan) if ACE inhibitors are not tolerated. 1
• Add a mineralocorticoid receptor antagonist (MRA) in patients with LVEF <40% and heart failure or diabetes, provided no renal failure or hyperkalemia. 1, 2

Monitoring and Surveillance

Perform routine echocardiography during hospital stay to assess LV and RV function, detect mechanical complications (papillary muscle rupture, ventricular septal defect), and exclude LV thrombus. 1

• Sudden hypotension, recurrent chest pain, new murmurs, pulmonary congestion, or jugular vein distension should raise suspicion for mechanical complications requiring immediate echocardiographic assessment. 4
• Have emergency equipment immediately available: atropine, defibrillator, transcutaneous pacing patches, and epinephrine. 1, 4

Common Pitfalls to Avoid

• Never assume absence of RV involvement without a right-sided ECG—clinical examination alone is insufficient. 3, 4
• Do not administer nitrates before excluding RV infarction, as this can precipitate catastrophic hypotension. 3, 4
• Avoid calcium channel blockers—they have not been shown to reduce mortality and may be harmful. 1, 4
• Do not switch between enoxaparin and UFH in the acute phase, as this increases bleeding risk. 2
• Discontinue NSAIDs (except aspirin) due to increased risks of mortality and reinfarction. 4